BC Thrombin Reagent
Test, Thrombin Time. 510(k) K970645, from Behring Diagnostics, Inc. (San Jose, CA). Product code GJA, class 2.
As of Nov 20, 2026, K970645 is an FDA 510(k) held by Behring Diagnostics, Inc., substantially equivalent on May 19, 1997 after 88 days, with 2 recalls tied to it in FDA's recall database.
- Review time: 88 days
- Recalls: 2
- Cited as a predicate by: 1 device
The BC Thrombin Reagent is used for the determination of the thrombin time in human plasma. The determination of thrombin time is important in: • The monitoring of heparin therapy. • The monitoring of fibrinolysis therapy. • The screening of disorders of fibrin formation. - The differentiating between a heparin-induced prolongation of the thrombin time and fibrin formation disorders.
- Stasis - I, Ii and Iii; Serathan - A, B; Intrin - Ea, Si Calcium Chloride 0.02M; Fibrinogen Control-Normal, LowK060968 · Wortham Laboratories, Inc. · May 15, 2007
| Oct 17, 2017 | Z-0827-2018The BC Thrombin Reagent kit lot 46751 (contains Thrombin Reagent lot 517468) and kit lot 47184 (contains Thrombin Reagent lot 517469) produce unexpected prolonged Thrombin Time (TT) results for expected normal samples,… | Terminated |
| Jul 21, 2004 | Z-0007-05The product does not demonstrate the expected prolonged thrombin times for specimens obtained from patients recieving heparin | Terminated |
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 20, 1997
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7875
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files